• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲病毒非结构蛋白 - 药物研发的潜在靶标。

Nonstructural Proteins of Alphavirus-Potential Targets for Drug Development.

机构信息

Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.

School of Biological Sciences, Nanyang Technological University, Singapore 636921, Singapore.

出版信息

Viruses. 2018 Feb 9;10(2):71. doi: 10.3390/v10020071.

DOI:10.3390/v10020071
PMID:29425115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5850378/
Abstract

Alphaviruses are enveloped, positive single-stranded RNA viruses, typically transmitted by arthropods. They often cause arthralgia or encephalitic diseases in infected humans and there is currently no targeted antiviral treatment available. The re-emergence of alphaviruses in Asia, Europe, and the Americas over the last decade, including chikungunya and o'nyong'nyong viruses, have intensified the search for selective inhibitors. In this review, we highlight key molecular determinants within the alphavirus replication complex that have been identified as viral targets, focusing on their structure and functionality in viral dissemination. We also summarize recent structural data of these viral targets and discuss how these could serve as templates to facilitate structure-based drug design and development of small molecule inhibitors.

摘要

甲病毒是有包膜的正单链 RNA 病毒,通常通过节肢动物传播。它们常引起感染人类的关节痛或脑炎疾病,目前尚无针对的抗病毒治疗方法。过去十年中,亚洲、欧洲和美洲的甲病毒再次出现,包括基孔肯雅病毒和奥尼昂昂病毒,这促使人们加紧寻找选择性抑制剂。在这篇综述中,我们重点介绍了在甲病毒复制复合物中已确定为病毒靶点的关键分子决定因素,重点关注它们在病毒传播中的结构和功能。我们还总结了这些病毒靶点的最新结构数据,并讨论了它们如何作为模板促进基于结构的药物设计和小分子抑制剂的开发。

相似文献

1
Nonstructural Proteins of Alphavirus-Potential Targets for Drug Development.甲病毒非结构蛋白 - 药物研发的潜在靶标。
Viruses. 2018 Feb 9;10(2):71. doi: 10.3390/v10020071.
2
Antiviral drug discovery against arthritogenic alphaviruses: Tools and molecular targets.抗关节炎甲病毒的抗病毒药物研发:工具和分子靶标。
Biochem Pharmacol. 2020 Apr;174:113777. doi: 10.1016/j.bcp.2019.113777. Epub 2019 Dec 23.
3
Inhibitors of the Structural and Nonstructural Proteins of Alphaviruses.α 病毒结构蛋白和非结构蛋白抑制剂。
ACS Infect Dis. 2024 Aug 9;10(8):2507-2524. doi: 10.1021/acsinfecdis.4c00254. Epub 2024 Jul 11.
4
Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs.Src 家族激酶抑制剂阻断甲病毒亚基因组 mRNAs 的翻译。
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.02325-18. Print 2019 Apr.
5
The C-Terminal Domain of Salmonid Alphavirus Nonstructural Protein 2 (nsP2) Is Essential and Sufficient To Block RIG-I Pathway Induction and Interferon-Mediated Antiviral Response.鲑鱼甲病毒非结构蛋白 2(nsP2)的 C 末端结构域是必需的和充分的,可阻断 RIG-I 通路诱导和干扰素介导的抗病毒反应。
J Virol. 2021 Nov 9;95(23):e0115521. doi: 10.1128/JVI.01155-21. Epub 2021 Sep 15.
6
Alphavirus RNA synthesis and non-structural protein functions.甲病毒RNA合成与非结构蛋白功能
J Gen Virol. 2015 Sep;96(9):2483-2500. doi: 10.1099/jgv.0.000249. Epub 2015 Jul 24.
7
Alphavirus Infection: Host Cell Shut-Off and Inhibition of Antiviral Responses.甲病毒感染:宿主细胞关闭及抗病毒反应抑制
Viruses. 2016 Jun 11;8(6):166. doi: 10.3390/v8060166.
8
Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication.脂肪酸合酶和硬脂酰辅酶 A 去饱和酶 1 是旧世界甲型病毒基因组复制的保守可药物靶点。
Antiviral Res. 2019 Dec;172:104642. doi: 10.1016/j.antiviral.2019.104642. Epub 2019 Oct 31.
9
New World alphavirus protein interactomes from a therapeutic perspective.从治疗角度看新世界阿尔巴病毒蛋白互作组。
Antiviral Res. 2019 Mar;163:125-139. doi: 10.1016/j.antiviral.2019.01.015. Epub 2019 Jan 26.
10
Targeting the alphavirus virus replication process for antiviral development.针对甲病毒的病毒复制过程进行抗病毒药物研发。
Antiviral Res. 2023 Feb;210:105494. doi: 10.1016/j.antiviral.2022.105494. Epub 2022 Dec 24.

引用本文的文献

1
Development Strategies for Influenza Vaccines Utilizing Phage RNA Polymerase and Capping Enzyme NP868R.利用噬菌体RNA聚合酶和加帽酶NP868R的流感疫苗开发策略
Chem Bio Eng. 2025 Jun 9;2(8):475-484. doi: 10.1021/cbe.5c00030. eCollection 2025 Aug 28.
2
Identification of Direct-Acting nsP2 Helicase Inhibitors with Antialphaviral Activity.具有抗α病毒活性的直接作用的nsP2解旋酶抑制剂的鉴定
J Med Chem. 2025 Jul 24;68(14):14514-14536. doi: 10.1021/acs.jmedchem.5c00635. Epub 2025 Jul 9.
3
Engineering gene expression dynamics via self-amplifying RNA with drug-responsive non-structural proteins.

本文引用的文献

1
β-d--Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome.β-d--羟基胞苷是一种有效的抗甲病毒化合物,可在病毒基因组中诱导高水平的突变。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01965-17. Print 2018 Feb 1.
2
A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses.小分子直接作用和宿主靶向抑制剂治疗甲病毒的纲要。
J Antimicrob Chemother. 2017 Nov 1;72(11):2973-2989. doi: 10.1093/jac/dkx224.
3
Cryo-electron tomography reveals novel features of a viral RNA replication compartment.
通过具有药物响应性非结构蛋白的自扩增RNA工程化基因表达动力学。
bioRxiv. 2025 Jun 8:2025.06.08.658495. doi: 10.1101/2025.06.08.658495.
4
Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches.针对蚊媒病毒的抗病毒策略进展:细胞、病毒及免疫相关方法
Virol J. 2025 Feb 4;22(1):26. doi: 10.1186/s12985-025-02622-z.
5
Leveraging Next-Generation Sequencing Application from Identity to Purity Profiling of Nucleic Acid-Based Products.利用下一代测序技术从核酸类产品的鉴定到纯度分析。
Pharmaceutics. 2024 Dec 28;17(1):30. doi: 10.3390/pharmaceutics17010030.
6
Mutations in chikungunya virus nsP4 decrease viral fitness and sensitivity to the broad-spectrum antiviral 4'-Fluorouridine.基孔肯雅病毒非结构蛋白4(nsP4)的突变会降低病毒适应性以及对广谱抗病毒药物4'-氟尿苷的敏感性。
PLoS Pathog. 2025 Jan 13;21(1):e1012859. doi: 10.1371/journal.ppat.1012859. eCollection 2025 Jan.
7
In Vitro Evaluation of the Anti-Chikungunya Virus Activity of an Active Fraction Obtained from Latex.从乳胶中获得的活性组分抗基孔肯雅病毒活性的体外评价
Viruses. 2024 Dec 17;16(12):1929. doi: 10.3390/v16121929.
8
Alphaviral backbone of self-amplifying RNA enhances protein expression and immunogenicity against SARS-CoV-2 antigen.自我扩增RNA的甲病毒骨架增强了针对SARS-CoV-2抗原的蛋白质表达和免疫原性。
Mol Ther. 2025 Feb 5;33(2):514-528. doi: 10.1016/j.ymthe.2024.12.055. Epub 2024 Dec 30.
9
The sticky business of Alphavirus capsid-host interactions.甲病毒衣壳与宿主相互作用的棘手问题。
Trends Microbiol. 2025 Mar;33(3):321-339. doi: 10.1016/j.tim.2024.11.003. Epub 2024 Dec 10.
10
Antiviral Potential of (L.) Hitchc. Plant Extracts Against and Viruses.(L.)Hitchc. 植物提取物的抗 和 病毒潜力。
Int J Mol Sci. 2024 Oct 23;25(21):11397. doi: 10.3390/ijms252111397.
冷冻电子断层扫描揭示了病毒RNA复制区室的新特征。
Elife. 2017 Jun 27;6:e25940. doi: 10.7554/eLife.25940.
4
Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1.[1,2,3]三唑并[4,5-d]嘧啶-7(6H)-酮类化合物抗基孔肯雅病毒的活性研究——针对病毒加帽酶 nsP1
Antiviral Res. 2017 Aug;144:216-222. doi: 10.1016/j.antiviral.2017.06.003. Epub 2017 Jun 12.
5
Chikungunya virus nsP4 RNA-dependent RNA polymerase core domain displays detergent-sensitive primer extension and terminal adenylyltransferase activities.基孔肯雅病毒非结构蛋白4(nsP4)的RNA依赖性RNA聚合酶核心结构域表现出对去污剂敏感的引物延伸和末端腺苷酸转移酶活性。
Antiviral Res. 2017 Jul;143:38-47. doi: 10.1016/j.antiviral.2017.04.001. Epub 2017 Apr 5.
6
Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.发现一种靶向基孔肯雅病毒非结构蛋白4(nsP4)的新型抗病毒剂。
Virology. 2017 May;505:102-112. doi: 10.1016/j.virol.2017.02.014. Epub 2017 Feb 23.
7
Alphavirus polymerase and RNA replication.甲病毒聚合酶与RNA复制
Virus Res. 2017 Apr 15;234:44-57. doi: 10.1016/j.virusres.2017.01.007. Epub 2017 Jan 16.
8
Structure-function relationship of Chikungunya nsP2 protease: A comparative study with papain.基孔肯雅病毒非结构蛋白2蛋白酶的结构-功能关系:与木瓜蛋白酶的比较研究
Chem Biol Drug Des. 2017 May;89(5):772-782. doi: 10.1111/cbdd.12901. Epub 2017 Jan 5.
9
Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.基孔肯雅病毒的感染性、RNA 复制和非结构多蛋白加工依赖于 nsP2 蛋白酶的活性位点半胱氨酸残基。
Sci Rep. 2016 Nov 15;6:37124. doi: 10.1038/srep37124.
10
Design and Validation of Novel Chikungunya Virus Protease Inhibitors.新型基孔肯雅病毒蛋白酶抑制剂的设计与验证
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7382-7395. doi: 10.1128/AAC.01421-16. Print 2016 Dec.